Cargando…

Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases

BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian carcinoma, associated with poor clinical outcome and metastatic disease. Although metastatic processes are becoming more understandable, the genomic landscape and metastatic progression in HGSOC has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masoodi, Tariq, Siraj, Sarah, Siraj, Abdul K., Azam, Saud, Qadri, Zeeshan, Parvathareddy, Sandeep K., Tulbah, Asma, Al-Dayel, Fouad, AlHusaini, Hamed, AlOmar, Osama, Al-Badawi, Ismail A., Alkuraya, Fowzan S., Al-Kuraya, Khawla S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156387/ https://www.ncbi.nlm.nih.gov/pubmed/32099096 http://dx.doi.org/10.1038/s41416-020-0763-4

Ejemplares similares

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
por: Masoodi, Tariq, et al.
Publicado: (2020)

Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach
por: Bu, Rong, et al.
Publicado: (2022)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

The study of Lynch syndrome in a special population reveals a strong founder effect and an unusual mutational mechanism in familial adenomatous polyposis
por: Siraj, Abdul K, et al.
Publicado: (2020)

Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity
por: Bu, Rong, et al.
Publicado: (2023)

Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2023)

Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients
por: Siraj, Abdul Khalid, et al.
Publicado: (2021)

Clonal Evolution and Timing of Metastatic Colorectal Cancer
por: Siraj, Sarah, et al.
Publicado: (2020)

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients
por: Siraj, Abdul K., et al.
Publicado: (2023)

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up
por: Siraj, Abdul K., et al.
Publicado: (2020)

High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer
por: Siraj, Abdul K, et al.
Publicado: (2021)

Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer
por: Siraj, Abdul Khalid, et al.
Publicado: (2022)

APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
por: Siraj, Sarah, et al.
Publicado: (2022)

FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2017)

PD-L1 Protein Expression in Middle Eastern Breast Cancer Predicts Favorable Outcome in Triple-Negative Breast Cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

Whole Exome-Wide Association Identifies Rare Variants in GALNT9 Associated with Middle Eastern Papillary Thyroid Carcinoma Risk
por: Bu, Rong, et al.
Publicado: (2023)

Microscopic Extrathyroidal Extension Results in Increased Rate of Tumor Recurrence and Is an Independent Predictor of Patient’s Outcome in Middle Eastern Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

PD-L1 Expression Is an Independent Marker for Lymph Node Metastasis in Middle Eastern Endometrial Cancer
por: Siraj, Abdul K., et al.
Publicado: (2021)

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)

Loss of ZNF677 Expression Is an Independent Predictor for Distant Metastasis in Middle Eastern Papillary Thyroid Carcinoma Patients
por: Siraj, Abdul K., et al.
Publicado: (2021)

Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region
por: Siraj, Abdul K., et al.
Publicado: (2019)

Male Sex Is an Independent Predictor of Recurrence-Free Survival in Middle Eastern Papillary Thyroid Carcinoma
por: Siraj, Abdul K., et al.
Publicado: (2022)

Risk Factors for Cervical Lymph Node Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Bilateral multifocality is an independent predictor of patients’ outcome in Middle Eastern papillary thyroid carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2023)

MED12 is recurrently mutated in Middle Eastern colorectal cancer
por: Siraj, Abdul K, et al.
Publicado: (2018)

Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2020)

SUN-132 KLF5 Is a Poor Prognostic Marker and Therapeutic Target for Middle Eastern Papillary Thyroid Carcinoma
por: Al-Kuraya, Khawla S, et al.
Publicado: (2020)

Tumor size is an independent negative prognostic factor for event free survival in children with differentiated thyroid cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Loss of ZNF677 expression is a predictive biomarker for lymph node metastasis in Middle Eastern Colorectal Cancer
por: Siraj, Abdul K., et al.
Publicado: (2021)

Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
por: Siraj, Abdul K., et al.
Publicado: (2020)

PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation
por: Siraj, Abdul K., et al.
Publicado: (2021)

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis
por: Bu, Rong, et al.
Publicado: (2016)

POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer
por: Siraj, Abdul K, et al.
Publicado: (2020)

Loss of CDH16 expression is a strong independent predictor for lymph node metastasis in Middle Eastern papillary thyroid cancer
por: Siraj, Abdul K., et al.
Publicado: (2023)

Risk Factors for Central Lymph Node Metastases and Benefit of Prophylactic Central Lymph Node Dissection in Middle Eastern Patients With cN0 Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qh7bkcidf12h7dbtgp0eu6dl1c